Nucleate New York Presents: Activator Demo Day 2026

​Nucleate New York's 5th Annual Ecosystem CelebrationNucleate New York’s Activator Demo Day marks the culmination of our flagship accelerator program - a celebration of the founders, operators, researchers, and investors building the future of biotech in NYC and beyond.

This year’s Demo Day will feature startup pitches from our 2026 Activator teams, curated panels with leading voices in biotech and venture, and meaningful networking across the ecosystem.

Whether you are investing in breakthrough science, advising early-stage companies, translating research from the bench, or building infrastructure for innovation, Demo Day is where emerging companies meet the capital, expertise, and community that move them forward.Featured Speakers:Agenda:

🎙️ What to Expect

Founder PitchesMeet Nucleate’s 2026 Activator teams as they present bold solutions across therapeutics, diagnostics, platform technologies, and biotech infrastructure. These founders represent the next generation of science-driven entrepreneurship.

Curated Industry PanelsHear from leaders across venture, pharma, law, and startup operations as they discuss the realities of building and financing biotech companies in today’s market.

Targeted NetworkingEngage directly with founders, investors, operators, and ecosystem partners. Demo Day is designed to facilitate substantive conversations, not just handshakes.

Why Attend?

Discover investable, early-stage biotech companiesConnect with NYC’s most active biotech buildersGain insight into emerging scientific and venture trendsStrengthen your position within the regional innovation ecosystem

Activator Demo Day 2026 is powered by Fenwick & West LLP and New York City Economic Development Corporation (NYCEDC)

​Nucleate New York's Activator program is supported by New York City Economic Development Corporation (NYCEDC), Wuxi App tec, Builds Bio and Brown Rudnick

About the Host:​

​Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.

​We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!

​​Platinum: Eli Lilly and Company, Genentech, Alnylam Pharmaceuticals, MilliporeSigma

Silver: Sanofi, CDD Vault

​Philanthropic Support: Lyda Hill Philanthropies

​Preferred Partners: Pillar VC, Amino Collective, Fenwick, Excedr, Mercury, Brex, Fedsprout, Browne Consulting

​In-Kind Support: AcademicLabs, Lens.org